Studies in mice and humans suggest that reducing cholesterol levels, through drugs like BM15.766 or statins, may decrease amyloid-beta production and AD prevalence, potentially influencing amyloid precursor protein (APP) processing. Here, APP is linked to Alzheimer disease.